Formulations and Methods of Administration of Cephalotaxines, Including Homoharringtonine
AssigneeChemGenex Pharmaceuticals, Inc.
InventorDennis M. Brown
Life of this patent
Estimating the term…
Abstract
The present invention is directed to compositions and methods for the treatment of patients with cephalotaxines, for example, homoharringtonine. The invention is also directed to improvements in the purity, manufacturing process, formulation and administration of homoharringtonine for the treatment of cancer and other aberrant cellular diseases. The invention also provides methods and compositions for antiparasitic, antifungal, antiviral and antibacterial treatments.
Claims28
A process for producing homoharringtonine, comprising:
- a) contacting a Cephalotaxus plant with citric acid to obtain an extraction mixture;
- b) adjusting the pH of the extraction mixture of a) to between about 8 and 9 with ammonia;
- c) extracting said extraction mixture of b) with chloroform;
- d) applying reduced pressure to the extraction mixture of c) to remove said chloroform;
- e) contacting the extraction mixture of d) with a silica gel column and eluting a purified extraction product;
- f) concentrating the purified extraction product of e);
- g) drying the concentrated purified extraction product of f);
- h) contacting the dried extraction product of g) with methanol to obtain a precipitate;
- and
- i) collecting said precipitate, wherein said precipitate comprises homoharringtonine.
An aqueous solution of HHT, wherein said solution is stable, wherein said solution is in a unit dosage form, wherein said solution is suitable for administration by injection.
A method of treatment of a host with an aberrant cellular condition, comprising contacting said host with a cephalotaxine in an amount sufficient to modulate the aberrant cellular condition, wherein said contacting is for at least 5 consecutive days.
Dependencies are inferred from the claim text.